The Immunology Podcast cover image

Ep. 36: “Engineered Immune Cell Therapies” Featuring Dr. Leonardo Ferreira

The Immunology Podcast

00:00

The RTS SAS 01 Malaria Vaccine

The RTS SAS 01, which was I think was a hot topic almost like five, seven years ago when it was the clinical trial was being run. This vaccine targets a antigen from the- what is known as the circum spursite protein from the spursite of plasmodium falciparum. The efficacy in the end was about 36%. So it was actually not great, better than nothing but not great.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app